Synchron and Festo introduce new ultra-high throughput DNA extraction device at SLAS 2019

During SLAS 2019, February 4-6 at the Walter E. Washington Convention Center in Washington, D.C., Synchron, with its automation partner Festo, describes for the first time the recent technology breakthrough leading to ultra-high throughput DNA extraction – up to 38,400 extractions per 24 hours.

The new Synchron DNA Cruiser extracts 38,400 DNA samples per 24 hours. This modular machine can be cost-effectively scaled for low, moderate, or high volume extraction applications.

A key section of the new extraction machine, the Synchron DNA Cruiser, along with 3D animation, are the centerpieces of the Festo SLAS Exhibit #1007.

Festo also introduces at the show a new telescoping slide for transporting samples to storage and demonstrates automation solutions for pre-analytic sample handling and precise microliter plate dispensing.

On February 5, from 12:30-1:15 in Room 143C, Business Development Leaders Niels Kruize, Synchron, and Wolfgang Trautwein, Festo, explain the breakthrough that led to the development of ultra-high throughput DNA extraction and the building of the DNA Cruiser. The first machine in the series is installed and engaged in agrigenomics research.         

The current model for DNA extraction involves handling samples in parallel. Synchron with Festo envisioned DNA extraction in series, rather than parallel, and saw the potential for extraction rates many times higher than previously possible.

The DNA Cruiser relies on automated liquid handling stations for each sequential step to achieve the volume required for ultra-high throughput extraction. The serial method also lends itself to other lab automation processes such as enzyme-linked immunosorbent assay (ELISA) and sample preparation.

The DNA Cruiser is built to Industry 4.0 concepts of modularity. Synchron can cost-effectively scale the extraction devices for specified volumes from low to high. Modules feature a small footprint to conserve valuable laboratory floor space.

Festo partners with life technology and biopharmaceutical equipment manufacturers and end users to provide system and sub-assembly process automation solutions. These partnerships enable customers to focus resources on their intellectual property while Festo supplies the automation utilized in:

  • Identification and evaluation
  • Dispensing and pipetting
  • Centrifuging
  • Incubation and shaking
  • Aspirating and dispensing
  • Storage

Late last year Festo opened its first engineering center in the United States devoted to the life sciences. The new center in Billerica, Mass., pioneers the development of high speed, high accuracy fluid handling automation based on pneumatic principles.

Center personnel also work with individual customers on automated motion and fluid handling solutions that help bring their laboratory device to market faster and at less cost.

See the Synchron DNA Cruiser display at the Festo Booth #1007. Write to Synchron at [email protected]. To learn more about Festo sample handling, dispensing, and storage automation solutions, visit the company’s laboratory automation webpage.

For more on the services of the Festo Life Tech Technical Engineering Center in Billerica, email [email protected]. The Festo general information number is 800-993-3786.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Society for Laboratory Automation and Screening (SLAS). (2019, June 18). Synchron and Festo introduce new ultra-high throughput DNA extraction device at SLAS 2019. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20190130/Synchron-and-Festo-introduce-new-ultra-high-throughput-DNA-extraction-device-at-SLAS-2019.aspx.

  • MLA

    Society for Laboratory Automation and Screening (SLAS). "Synchron and Festo introduce new ultra-high throughput DNA extraction device at SLAS 2019". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20190130/Synchron-and-Festo-introduce-new-ultra-high-throughput-DNA-extraction-device-at-SLAS-2019.aspx>.

  • Chicago

    Society for Laboratory Automation and Screening (SLAS). "Synchron and Festo introduce new ultra-high throughput DNA extraction device at SLAS 2019". News-Medical. https://www.news-medical.net/news/20190130/Synchron-and-Festo-introduce-new-ultra-high-throughput-DNA-extraction-device-at-SLAS-2019.aspx. (accessed November 21, 2024).

  • Harvard

    Society for Laboratory Automation and Screening (SLAS). 2019. Synchron and Festo introduce new ultra-high throughput DNA extraction device at SLAS 2019. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20190130/Synchron-and-Festo-introduce-new-ultra-high-throughput-DNA-extraction-device-at-SLAS-2019.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pharmatech: The Art of AI-Driven Drug Design with Exscientia